Familiáris hiperkoleszterinémia: vizsgálatok itt: Ausztria
4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 17.. Ask the study team whether a trial fits you.
- 3. fázisNot yet taking people in AusztriaStudy to evaluate efficacy and safety of inclisiran in children aged 2 to under 12 years of age with homozygous familial hypercholesterolemia
- Where
- Vienna
- Életkor
- Up to 17 év
- People
- 8 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2024-514595-41-00 - 3. fázisTaking peopleStudy to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
- Where
- Vienna
- Életkor
- 2 év to 11 év
- People
- 9 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06597006 - 4. fázisTaking peopleEarly TRIPLE versus dual LIPID lowering treatment in peOple with atherosclerotic cardiovascular disease and hypercholesterolemia Undergoing elecTive revascularisation
- Where
- Feldkirch, Graz, Klagenfurt Am Woerthersee
- Életkor
- 18 év and over
- People
- 160 worldwide
- Run by
- Medical University Of Graz
See details and how to join2026-525917-29-00 - 3. fázisTaking peopleStudy to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
- Where
- Salzburg, Vienna
- Életkor
- 6 év to 11 év
- People
- 60 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06597019